Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population

被引:36
|
作者
Yamazaki, Hiroshi [1 ]
Fujita, Haruka
Gunji, Takaaki
Zhang, Jun
Kamataki, Tetsuya
Cashman, John R.
Shimizu, Makiko
机构
[1] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo 1948543, Japan
[2] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan
[3] Human Biomol Res Inst, San Diego, CA 92121 USA
关键词
flavin-containing monooxygenase; fish-like odor syndrome; trimethylamine; truncated FMO3; Japanese; trimethylaminuria;
D O I
10.1016/j.ymgme.2006.08.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The reduced capacity of flavin-containing monooxygenase 3 (FMO3) to N-oxidize trimethylamine (TMA) is believed to cause a metabolic disorder. The aim of this study was to investigate the inter-individual variations of FMO3. Genomic DNA of case subjects that showed only 10-20% of FMO3 metabolic capacity among self-reported trimethylaminuria Japanese volunteers was sequenced. Functional analysis of recombinant FMO3 proteins was also performed. One homozygote for a novel single nucleotide substitution causing a stop codon at Arg500 was observed. The biological parents of this Proband A were heterozygous and showed > 90% TMA N-oxygenation metabolic capacity. Another Proband B had the Arg500Stop and Cys197Stop codons. The TMA N-oxygenation metabolic capacities of the father and brother of this Proband B were apparently observed by possessing Arg205Cys mutant that coded for decreased TMA N-oxygenase. Recombinant Arg500Stop FMO3 cDNA expressed in Escherichia coli membranes and a series of highly purified truncation mutants at different positions of the C-terminus of FMO3 showed no detectable functional activity toward typical FMO3 substrates. The results suggest that individuals homozygous for either of the nonsense mutations, Arg500Stop and/or Cys197Stop alleles, in the FMO3 gene can possess abnormal TMA N-oxygenation. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 50 条
  • [21] Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort
    Akerman, BR
    Lemass, H
    Chow, LML
    Lambert, DM
    Greenberg, C
    Bibeau, C
    Mamer, OA
    Treacy, EP
    MOLECULAR GENETICS AND METABOLISM, 1999, 68 (01) : 24 - 31
  • [22] Complex mechanism underlying transcriptional control of the haplotyped flavin-containing monooxygenase 3 (FMO3) gene in Japanese:: Different regulation between mutations in 5′-upstream distal region and common element in proximal region
    Shimizu, Makiko
    Murayama, Norie
    Nagashima, Satomi
    Fujieda, Masaki
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2008, 23 (01) : 54 - 58
  • [23] Novel variants and haplotypes of human flavin-containing monooxygenase 3 gene associated with Japanese subjects suffering from trimethylaminuria
    Shimizu, Makiko
    Yoda, Hiromi
    Igarashi, Narumi
    Makino, Miki
    Tokuyama, Emi
    Yamazaki, Hiroshi
    XENOBIOTICA, 2019, 49 (10) : 1244 - 1250
  • [24] Sequence variations in the flavin-containing mono-oxygenase 3 gene (FMO3) in fish odour syndrome
    Basarab, T
    Ashton, GHS
    Menagé, HD
    McGrath, JA
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 140 (01) : 164 - 167
  • [25] Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure
    Zhou, Wangda
    Humphries, Helen
    Neuhoff, Sibylle
    Gardner, Iain
    Masson, Eric
    Al-Huniti, Nidal
    Zhou, Diansong
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (06) : 389 - 393
  • [26] Three novel single nucleotide polymorphisms of the FMO3 gene in a Japanese population
    Shimizu, Makiko
    Fujita, Haruka
    Aoyama, Takahiko
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2006, 21 (03) : 245 - 247
  • [27] Simple confirmation methods for rare but impaired variants of human flavin-containing monooxygenase 3 (FMO3) found in an updated genome resource databank
    Shimizu, Makiko
    Makiguchi, Miaki
    Yokota, Yuka
    Shimamura, Erika
    Matsuta, Moegi
    Nakamura, Yuria
    Harano, Mizuki
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 53
  • [28] A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome:: activity of the mutant enzyme assessed by proton NMR spectroscopy
    Murphy, HC
    Dolphin, CT
    Janmohamed, A
    Holmes, HC
    Michelakakis, H
    Shephard, EA
    Chalmers, RA
    Phillips, IR
    Iles, RA
    PHARMACOGENETICS, 2000, 10 (05): : 439 - 451
  • [29] Isoform specificity of trimethylamine N-oxygenation by human flavin containing monooxygenase (FMO) and P450 enzymes -: Selective catalysis by FMO3
    Lang, DH
    Yeung, CK
    Peter, RM
    Ibarra, C
    Gasser, R
    Itagaki, K
    Philpot, RM
    Rettie, AE
    BIOCHEMICAL PHARMACOLOGY, 1998, 56 (08) : 1005 - 1012
  • [30] Flavin-containing monooxygenase 3 and human disease
    Motika, Meike S.
    Zhang, Jun
    Cashman, John R.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (06) : 831 - 845